期刊文献+

SELDI-TOF质谱技术分析家族性腺瘤性息肉病血清蛋白质谱 被引量:1

Analysis of Proteomics Spectra in Serum from Patients with FAP by SELDI-TOF Mass Spectrometry
下载PDF
导出
摘要 目的研究家族性腺瘤性息肉病患者血清蛋白质的变化,建立灵敏度和特异度高的家族性腺瘤性息肉病诊断模型。方法利用SELDI-TOF-MS技术对18例家族性腺瘤性息肉病患者术前、术后血清蛋白质分别进行检测,IMAC30芯片结合蛋白质后,用蛋白芯片仪读取数据,分析得到区分两组的树状分类规则,并构建诊断模型。结果 M8514.89蛋白质组成的模型可将两组准确分组,灵敏度和特异度分别为88.89%(16/18)和100%(18/18)。结论 SELDI-TOF MS技术可将家族性腺瘤性息肉病术前、术后正确分组,可应用于家族性腺瘤性息肉病的诊断、鉴别、随访和手术时机的选择。 Objective To research the serum protein of FAP patients, and establish the diagnostic model of FAP with high sensitivity and specificity in application. Methods Samples of sera with 18 preoperative and postoperative FAP patients were detected by surface enhanced laser desorption/ionization time of flight mass spectrometry SELDI-TOF MS, After the surface of chips IMAC30 bind the serum protein, proteinchip reader of ciphergen inc, a part of SELDI-TOF MS, would detect the signs. Then the classification rule of tree was discoverer. The model of identification of FAP would be constructed by the classification rule of tree. Results At the key M/Z values of M8514.89 protein contents of the two classes are obviously different by the software analysis. And corresponding sensitivity was 88.89% (16/18) and corresponding specificity was 100% (18/18). Conclusion THE SELDI-TOF MS could be used in the diagnosis, identification, follow-up and operative juncture of FAP.
出处 《河南科技大学学报(医学版)》 2012年第4期251-252,共2页 Journal of Henan University of Science & Technology:Medical Science
关键词 家族性腺瘤性息肉病 生物标记物 蛋白质组学 质谱 表面增强激光解吸离子化时间飞行质谱 adenomatous polyposis coli biomarkers proteomics mass spectrometry, SELDI-TOF MS
  • 相关文献

参考文献4

二级参考文献13

  • 1高春芳,李冬晖,赵光,郑国宝,王秀丽,许红兵.胃癌患者血清比较蛋白质组学研究[J].解放军医学杂志,2005,30(6):457-459. 被引量:20
  • 2Chen YD, Zheng S, Yu JK et al. Development of serum biomarker model and its application in colorectal cancer diagnosis. J Rumor Marder Oncology,2003,19(3):251
  • 3Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology [J]. BMJ, 2000, 321:805 - 808.
  • 4Ezzell C. Beyond the human genome [J ]. Sci Am, 2000, 283 ( 1 ):64 - 69.
  • 5Srinivas PR, Verma M, Zhao Y, et al. Proteomics for cancer biomarker discovery [ J ]. Clin Chem, 2002, 48 (8): 1160 - 1169.
  • 6Weinberger SR, Morris TS, Pawlak M, et al. Recent trends in protein biochip technology [ J ]. Pharmacogenomics, 2000, 1 (4):395 - 461.
  • 7Merchant M, Weinberge SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry [ J ]. Electrophoresis, 2000, 21 (6): 1164 - 1177.
  • 8Emmert-Buck MR, Gillespie JW, Paweletz CP, et al. An approach to proteomic analysis of human tumors [J]. Mol Carcinog, 2000,27(3): 158 - 165.
  • 9Davies HA. The ProteinChip System from Ciphergen: A new technique for rapid, micro-scale protein biology [J]. J Mol Med,2000,78(7): B29.
  • 10Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer [J] . Lancet, 2002,359(9306): 572 - 577.

共引文献39

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部